Thermo Fisher(DE:TN8)
€652.80+12.00 (+1.87%)
DE:TN8
Thermo Fisher stock forecast
€652.80
At close:+12.00 (+1.87%)
Thermo Fisher (TN8) Stock Forecast & Price Target
8 Followers
TN8 Analyst Ratings
Strong Buy
15Buy3Hold0Sell
Based on 18 analysts giving stock ratings to Thermo Fisher in the past 3 months
TN8 Stock 12 Month Forecast
Average Price Target
€678.18▲(3.89% Upside)Based on 18 Wall Street analysts offering 12 month price targets for Thermo Fisher in the last 3 months. The average price target is EUR 678.18 with a high forecast of EUR 743.14 and a low forecast of EUR 514.83. The average price target represents a 3.89% change from the last price of EUR 652.80.
Past 12 Months12 Month ForecastJan2026Oct2026
High€743.14
Average€678.18
Low€514.83
Highest Price TargetHighest€743.14Average Price Target€678.18Lowest Price TargetLowest€514.83
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Luke Sergott | Barclays | €693.90 | buy | 6.30%Upside | Reiterated | 11/02/26 | ||
 Unknown AnalystNot Ranked | Guggenheim | €662.56 | buy | 1.49%Upside | Reiterated | 11/02/26 | ||
| Avantika Dhabaria | Bank of America Securities | €711.80 | buy | 9.04%Upside | Reiterated | 10/30/26 | ||
| David Toung | Argus Research | €501.40→€698.37 | buy | 6.98%Upside | Assigned | 10/29/26 | ||
| Aristotelis Moutopoulos | DZ BANK AG | €564.07→€581.98 | hold | -10.85%Downside | Downgraded | 10/23/26 | ||
| Patrick B Donnelly | Citi | €613.31→€716.28 | buy | 9.72%Upside | Reiterated | 10/23/26 | ||
| Jill Wu | CMB International Securities | €590.93→€716.28 | buy | 9.72%Upside | Reiterated | 10/23/26 | ||
| Catherine Ramsey Schulte | Robert W. Baird | €647.34→€676.88 | buy | 3.69%Upside | Reiterated | 10/22/26 | ||
| Daniel Arias | Stifel Nicolaus | €581.98→€693.90 | buy | 6.30%Upside | Reiterated | 10/22/26 | ||
| Dan Leonard | RBC Capital | €519.30→€653.61 | hold | 0.12%Upside | Assigned | 10/22/26 | ||
| Daniel Brennan | TD Cowen | €680.47→€725.23 | buy | 11.10%Upside | Assigned | 10/22/26 | ||
| Doug Schenkel | UBS | €716.28 | buy | 9.72%Upside | Reiterated | 10/22/26 | ||
| Casey Woodring | J.P. Morgan | €680.47→€734.19 | buy | 12.47%Upside | Reiterated | 10/22/26 | ||
| Evie Koslosky | Goldman Sachs | €698.37→€743.14 | buy | 13.84%Upside | Reiterated | 10/21/26 | ||
| Eve Burstein | Bernstein | €514.83 | hold | -21.14%Downside | Assigned | 10/19/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Luke SergottBarclays | BuyReiterated€693.90 | 11/02/26 | 6.30%Upside | ||
| Unknown AnalystGuggenheimNot Ranked | BuyReiterated€662.56 | 11/02/26 | 1.49%Upside | ||
| Avantika DhabariaBank of America Securities | BuyReiterated€711.80 | 10/30/26 | 9.04%Upside | ||
| David ToungArgus Research | BuyAssigned€501.40→€698.37 | 10/29/26 | 6.98%Upside | ||
| Aristotelis MoutopoulosDZ BANK AG | HoldDowngraded€564.07→€581.98 | 10/23/26 | -10.85%Downside | ||
| Patrick B DonnellyCiti | BuyReiterated€613.31→€716.28 | 10/23/26 | 9.72%Upside | ||
| Jill WuCMB International Securities | BuyReiterated€590.93→€716.28 | 10/23/26 | 9.72%Upside | ||
| Catherine Ramsey SchulteRobert W. Baird | BuyReiterated€647.34→€676.88 | 10/22/26 | 3.69%Upside | ||
| Daniel AriasStifel Nicolaus | BuyReiterated€581.98→€693.90 | 10/22/26 | 6.30%Upside | ||
| Dan LeonardRBC Capital | HoldAssigned€519.30→€653.61 | 10/22/26 | 0.12%Upside | ||
| Daniel BrennanTD Cowen | BuyAssigned€680.47→€725.23 | 10/22/26 | 11.10%Upside | ||
| Doug SchenkelUBS | BuyReiterated€716.28 | 10/22/26 | 9.72%Upside | ||
| Casey WoodringJ.P. Morgan | BuyReiterated€680.47→€734.19 | 10/22/26 | 12.47%Upside | ||
| Evie KosloskyGoldman Sachs | BuyReiterated€698.37→€743.14 | 10/21/26 | 13.84%Upside | ||
| Eve BursteinBernstein | HoldAssigned€514.83 | 10/19/26 | -21.14%Downside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Thermo Fisher
3 Months
Success Rate22/30 ratings generated profit
73%
Average Return
+4.86%
Copying Daniel Arias's trades and holding each position for 3 Months would result in 73.33% of your transactions generating a profit, with an average return of +4.86% per trade.
1 Year
Success Rate18/19 ratings generated profit
95%
Average Return
+21.72%
Copying Doug Schenkel's trades and holding each position for 1 Year would result in 94.74% of your transactions generating a profit, with an average return of +21.72% per trade.
2 Years
Success Rate18/19 ratings generated profit
95%
Average Return
+43.66%
Copying Doug Schenkel's trades and holding each position for 2 Years would result in 94.74% of your transactions generating a profit, with an average return of +43.66% per trade.
TN8 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 30 | 22 | 23 | 24 | 25 |
| Hold | 8 | 6 | 6 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 38 | 28 | 29 | 31 | 32 |
In the current month, TN8 has received 25 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. TN8 average Analyst price target in the past 3 months is 678.18.
TN8 Financial Forecast
High€6.51
Consensus€6.39
Low€6.27
TN8 Earnings Forecast
Next quarter’s earnings estimate for TN8 is EUR 6.39 with a range of EUR 6.27 to EUR 6.51. The previous quarter’s EPS was EUR 5.98. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High€11.6B
Consensus€11.5B
Low€11.4B
TN8 Sales Forecast
Next quarter’s sales forecast for TN8 is EUR 11.50B with a range of EUR 11.38B to EUR 11.63B. The previous quarter’s sales results were EUR 10.87B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
TN8 Stock Forecast FAQ
What is DE:TN8’s average 12-month price target, according to analysts?
Based on analyst ratings, Thermo Fisher’s 12-month average price target is €678.18.
What is DE:TN8’s upside potential, based on the analysts’ average price target?
Thermo Fisher has 3.89% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Thermo Fisher a Buy, Sell or Hold?
Thermo Fisher has a consensus rating of Strong Buy, which is based on 15 buy ratings, 3 hold ratings and 0 sell ratings.
What is Thermo Fisher’s share price target?
The average share price target for Thermo Fisher is €678.18. This is based on 18 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €743.14, and the lowest forecast is €514.83. The average share price target represents a 3.89% increase from the current price of €652.8.
What do analysts say about Thermo Fisher?
Thermo Fisher’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Street analysts.
How can I buy shares of Thermo Fisher?
To buy shares of DE:TN8, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
